Skip to main content
Clinical Trials/NCT02731430
NCT02731430UnknownPhase 2

Intrathecal Morphine for Postoperative Pain Management in Patients Undergoing Laparoscopic Bariatric Surgery

Assiut University0 sites100 target enrollmentStarted: December 2015Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 2
Enrollment
100
Primary Endpoint
Total postoperative analgesic consumption.

Study Overview

Brief Summary

this study compares the use of intrathecal morphine, to multimodal analgesic techniques for postoperative pain management following laparoscopic bariatric surgery.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Treatment
Masking
Triple (Participant, Care Provider, Investigator)

Eligibility Criteria

Ages
20 Years to 50 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • American Society of Anesthesia (ASA) II-III patients.
  • Aged 30-50 years.
  • The body mass index (BMI) of the patients needed to be over 40 kg/m² or over 35 kg/m² with at least one comorbidity.

Exclusion Criteria

  • Patients with a known allergy to the study drugs.
  • Advanced cardiac, respiratory, renal or hepatic disease.
  • Coagulation disorders.
  • Infection at or near the site of intrathecal injection.
  • Drug or alcohol abuse.
  • Psychiatric illnesses that may interfere with perception and assessment of pain.

Arms & Interventions

group I: morphine group

Active Comparator

received 0.3mg morphine (0.3ml) added to 1.2ml of bupivacaine 0.5% (total volume 1.5ml), intrathecally, immediately before induction of general anesthesia.

Intervention: intrathecal morphine (Drug)

group II: control group

Placebo Comparator

received 0.3ml saline added to 1.2mlof bupivacaine 0.5% (total volume 1.5ml), intrathecally, immediately before induction of general anesthesia.

Intervention: intrathecal saline (Drug)

Outcomes

Primary Outcomes

Total postoperative analgesic consumption.

Time Frame: 24 hours postoperative

the efficacy of the studied dose of intrathecal morphine in reducing postoperative analgesic consumption.

Secondary Outcomes

  • Time to first request of rescue analgesia.(24 hours postoperative)
  • Visual analogue scale (VAS) scores(24 hours postoperative)
  • Tolerability as assessed by the incidence of side effects(24 hours postoperative)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ahmad Mohammad Abd El-Rahman

Lecturer of anesthesia, icu, and pain management

Assiut University

Similar Trials

Intrathecal Morphine for Postoperative... | Clinical Trial